Literature DB >> 26770388

Association between EPHX1 rs1051740 and lung cancer susceptibility: a meta-analysis.

Peng Zhang1, Youzhi Zhang1, Haihua Yang1, Wenjing Li1, Xiaodong Chen1, Feng Long1.   

Abstract

BACKGROUND: Microsomal epoxide hydrolase 1 (EPHX1) may play an important role in epigenetic change and DNA repair concerned with lung cancer. Several studies have investigated the association between EPHX1 rs1051740 and lung cancer risk, but there is no consensus. Therefore, we performed a meta-analysis to further identify the relationship.
METHODS: The Pubmed and Embase databases were searched for eligible studies. An odds ratio (OR) with 95% confidence intervals (CIs) was used to assess the correlation between EPHX1 rs1051740 polymorphism and lung cancer risk through a meta-analysis.
RESULTS: Overall, no significant relationship was found between EPHX1 rs1051740 and lung cancer risk (CC vs. TT: OR=1.10, 95% CI=0.88-1.36; CC+CT vs. TT: OR=1.02, 95% CI=0.88-1.18; CC vs. TT+CT: OR=1.08, 95% CI=0.91-1.27; C vs. T: OR=1.04, 95% CI=0.93-1.17; CT vs. TT: OR=0.98, 95% CI=0.85-1.13). Nevertheless, further subgroup analysis by ethnicity demonstrated that EPHX1 rs1051740 with CC genotype or C allele was an increased risk for lung cancer in Asians (CC vs. TT: OR=1.54, 95% CI=1.23-1.94; CC vs. TT+CT: OR=1.43, 95% CI=1.20-1.71; C vs. T: OR=1.26, 95% CI=1.08-1.47).
CONCLUSIONS: This meta-analysis indicates that EPHX1 rs1051740 with CC genotype or C allele may be a risk factor in Asians.

Entities:  

Keywords:  EPHX1; lung cancer; polymorphism

Year:  2015        PMID: 26770388      PMCID: PMC4694288     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  37 in total

Review 1.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.

Authors:  Linda M Dong; John D Potter; Emily White; Cornelia M Ulrich; Lon R Cardon; Ulrike Peters
Journal:  JAMA       Date:  2008-05-28       Impact factor: 56.272

Review 2.  Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials.

Authors:  Wei-Xiang Qi; Shen Fu; Qing Zhang; Xiao-Mao Guo
Journal:  Curr Med Res Opin       Date:  2014-10-30       Impact factor: 2.580

3.  Association of functionally important polymorphism of microsomal epoxide hydrolase gene (EPHX1) with lung cancer susceptibility.

Authors:  Anup R Tilak; Sachin Kumar; Meenu Jain; Mohan C Pant; Bhudev C Das; Randeep Guleria; Balraj Mittal; Neeraj Mathur; Ashwani Kumar
Journal:  Cancer Invest       Date:  2011-07       Impact factor: 2.176

4.  Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.

Authors:  M Kmetov Sivonova; D Dobrota; T Matakova; R Dusenka; S Grobarcikova; V Habala; J Salagovic; M Tajtakova; A Pidanicova; L Valansky; L Lachvacs; J Kliment; V Nagy; J Kliment
Journal:  Neoplasma       Date:  2012       Impact factor: 2.575

5.  Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene-exposed workers.

Authors:  Caihong Xing; Qi Chen; Guilan Li; Linyuan Zhang; Min Zheng; Zhengyong Zou; Lifang Hou; Qian-Fei Wang; Xin Liu; Xinbiao Guo
Journal:  Environ Mol Mutagen       Date:  2013-06-25       Impact factor: 3.216

6.  Low microsomal epoxide hydrolase expression is associated with bladder carcinogenesis and recurrence.

Authors:  Zhe Zhang; Xiu-Yue Yu; Guo-Jun Zhang; Kun-Feng Guo; Chui-Ze Kong
Journal:  Asian Pac J Cancer Prev       Date:  2012

7.  Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer.

Authors:  Rama D Mittal; Dayashankar L Srivastava
Journal:  DNA Cell Biol       Date:  2007-11       Impact factor: 3.311

Review 8.  Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.

Authors:  Fei Liu; Ding Yuan; Yonggang Wei; Wentao Wang; Lvnan Yan; Tianfu Wen; Mingqing Xu; Jiayin Yang; Bo Li
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

9.  The role of TGF-β1-miR-21-ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells.

Authors:  Y Jiang; X Chen; W Tian; X Yin; J Wang; H Yang
Journal:  Br J Cancer       Date:  2014-07-03       Impact factor: 7.640

10.  The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study.

Authors:  L F Forrest; M White; G Rubin; J Adams
Journal:  Br J Cancer       Date:  2014-06-10       Impact factor: 7.640

View more
  3 in total

1.  Missense Genetic Polymorphisms of Microsomal (EPHX1) and Soluble Epoxide Hydrolase (EPHX2) and Their Relation to the Risk of Large Artery Atherosclerotic Ischemic Stroke in a Turkish Population.

Authors:  Birsen Can Demirdöğen; Yağmur Miçooğulları; Aysun Türkanoğlu Özçelik; Orhan Adalı
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-07       Impact factor: 2.570

2.  The effect on congenital heart diseases of maternal EPHX1 polymorphisms modified by polycyclic aromatic hydrocarbons exposure.

Authors:  Jing Tao; Nana Li; Zhen Liu; Ying Deng; Xiaohong Li; Ming Chen; Jing Yu; Jun Zhu; Ping Yu; Yanping Wang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 3.  Regulation of cardiovascular biology by microsomal epoxide hydrolase.

Authors:  Matthew L Edin; Darryl C Zeldin
Journal:  Toxicol Res       Date:  2021-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.